Published in Am J Physiol on July 01, 1983
Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics (2010) 1.19
Hyperammonaemia causes many of the changes found after portacaval shunting. Biochem J (1990) 0.94
15N n.m.r. measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat. Biochem J (1993) 0.91
Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis. Biochem J (1991) 0.84
Brain edema in acute liver failure: role of neurosteroids. Arch Biochem Biophys (2013) 0.80
Ketone-body utilization by adult and suckling rat brain in vivo. Biochem J (1971) 3.32
A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta (1975) 2.64
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology (2009) 2.37
Erroneous mass spectrometer data caused by a faulty patient sampling tube: case report and laboratory study. J Clin Monit (1991) 2.36
Oestrogen receptors and breast cancer: current status. Br J Surg (1980) 2.31
Estrogen secretion by the rat ovary in vivo during the estrous cycle and pregnancy. Endocrinology (1969) 2.25
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med (2001) 2.04
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med (1990) 1.85
Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer (1977) 1.85
Anaesthetic-induced malignant hyperpyrexia and a method for its prediction. Br J Anaesth (1969) 1.83
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer (1978) 1.71
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol (1998) 1.64
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Oestrogen receptor concentration in primary breast cancer and axillary node metastases. Breast Cancer Res Treat (1981) 1.64
Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab (1986) 1.62
A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. J Nucl Med (1993) 1.53
Measurements of substrate uptake by mammary gland of the rat. Biochem J (1972) 1.51
Purine transport in polymorphonuclear leukocytes. Biochim Biophys Acta (1969) 1.51
Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer (1994) 1.48
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
The effect of acetoacetate on plasma insulin concentration. Biochem J (1971) 1.44
Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. Eur J Cancer (1978) 1.43
Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab (1993) 1.42
A human tumour model. Lancet (1986) 1.39
Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. J Nucl Med (1991) 1.38
Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet (1989) 1.37
Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. J Nucl Med (1995) 1.36
Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol (1998) 1.35
Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med (1985) 1.34
Effect of glucagon on hepatic malonyl coenzyme A concentration and on lipid synthesis. J Biol Chem (1977) 1.28
Measurement of oestradiol receptors by five institutions on common tissue samples. Br J Cancer (1978) 1.26
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer (1990) 1.24
Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem (1999) 1.23
Editorial: And yet another crisis: research funding in anesthesiology. Anesthesiology (1974) 1.22
Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg (1989) 1.22
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br J Cancer (1989) 1.20
Primary systemic therapy for operable breast cancer. Br J Cancer (1991) 1.19
Hyperpyrexia during anaesthesia. Br Med J (1968) 1.17
Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol (1991) 1.17
Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr (1993) 1.15
Ketone bodies are selectively used by individual brain regions. Science (1979) 1.15
Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol (1986) 1.15
Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique. Br J Cancer (1986) 1.13
Whole-body positron emission tomography: Part I. Methods and performance characteristics. J Nucl Med (1992) 1.12
The acute action of ammonia on rat brain metabolism in vivo. Biochem J (1973) 1.11
Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res (1995) 1.10
Pseudoparasitic (Liesegang) bodies in paranasal sinus. J Laryngol Otol (1988) 1.10
The effects of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) on glycolysis and biosynthetic processes of the isolated perfused rat liver. Biochem J (1972) 1.10
Comparison of the effects of hormones on DNA synthesis in cell cultures of nonneoplastic and neoplastic mammary epithelium from rats. Cancer Res (1977) 1.09
Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position. Am J Physiol (1985) 1.07
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. Br J Cancer (1997) 1.07
Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope (1992) 1.07
Whole body skeletal imaging with [18F]fluoride ion and PET. J Comput Assist Tomogr (1993) 1.07
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG. J Nucl Med (2001) 1.06
Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia (1973) 1.05
Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET. J Comput Assist Tomogr (1992) 1.05
Receptors in the management of breast cancer. Br J Hosp Med (1985) 1.05
Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity. Br J Cancer (1986) 1.03
Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med (1994) 1.02
Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med (1991) 1.02
Comparison of the effects of volatile anesthetics on brain glucose metabolism in rats. Anesthesiology (1987) 1.01
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol (1994) 1.01
Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med (1993) 0.99
Oestradiol-17 beta and prolactin levels in rat peripheral plasma. Br J Cancer (1975) 0.99
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res (1998) 0.99
Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol (1985) 0.99
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer (1990) 0.99
Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol (1998) 0.99
Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging (1998) 0.98
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology (1999) 0.97
Estimation of oestrone sulphate, oestradiol-17beta and oestrone in peripheral plasma: concentrations during the menstrual cycle and in men. J Endocrinol (1974) 0.97
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer (1988) 0.97
Sex hormone receptors in intracranial tumours and normal brain. Eur J Surg Oncol (1987) 0.96
Elastosis and oestrogen receptors in human breast cancer. Br J Cancer (1976) 0.96
Steroid metabolism and oestrogen receptors in human breast carcinomas. Eur J Cancer Clin Oncol (1981) 0.96
Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol (1997) 0.96
Histochemical detection of oestrogen receptors: a progress report. Br J Cancer (1982) 0.95
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer (1989) 0.95
Sleep neurobiology: relevance for mechanistic studies of anaesthesia. Br J Anaesth (1994) 0.95
Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med (1992) 0.95
How best to express oestrogen receptor activity. Br J Cancer (1996) 0.94
Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11. J Pathol (1986) 0.94
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer (1993) 0.94
Concerning the ethics and accuracy of scientific citations. Anesthesiology (1992) 0.94
Hyperammonaemia causes many of the changes found after portacaval shunting. Biochem J (1990) 0.94
Oestrogen receptor concentration and macrophage infiltration in human breast cancer. Eur J Surg Oncol (1986) 0.94
The plasma creatinine concentration is not an accurate reflection of the glomerular filtration rate in stable renal transplant patients receiving cyclosporine. Am J Kidney Dis (1987) 0.93
Estrogen regulation of transforming growth factor-alpha in ovarian cancer. J Steroid Biochem Mol Biol (1998) 0.93
Measurement of the rate of glucose utilization by rat brain in vivo. J Neurochem (1974) 0.93
Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem (1993) 0.93
Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem (2001) 0.92
Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J Neurochem (1979) 0.92
In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology (2001) 0.92